Differential involvement of the Fas receptor/ligand system in p53-dependent apoptosis in human prostate cancer cells

Prostate

Volumn 45, Issue 4, 2000, Pages 341-349

  Hara, Isao ^a   Miyake, Hideaki ^a,b   Hara, Shoji ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Apoptosis; Fas; Fas ligand; p53; Prostate cancer

Indexed keywords

FAS ANTIGEN; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CYTOTOXICITY; DNA DAMAGE; GENE EXPRESSION REGULATION; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANTIGENS, CD95; APOPTOSIS; DNA FRAGMENTATION; FAS LIGAND PROTEIN; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MEMBRANE GLYCOPROTEINS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033670042     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001201)45:4<341::AID-PROS9>3.0.CO;2-M     Document Type: Article

References (20)

1. Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
2. Target to apoptosis: A hopeful weapon for prostate cancer
3. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model
4. The emerging p53 gene family
5. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
6. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells
7. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer
8. Enhancement of chemosensitivity in human bladder cancer cells by adnoviral-mediated p53 gene transfer
9. Fas-induced apoptosis, and disease caused by its abnormality
10. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
11. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turn over
12. Fas-mediated apoptosis in human prostatic carcinoma cells
13. Chemosensitization of human pros tate carcinoma cell lines to anti-Fas-mediated cytotoxicity and apoptosis
14. Fas ligand is constitutively secreted by prostate cancer cells in vitro
15. Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis
16. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
17. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis
18. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen-independence in prostate cancer
19. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
20. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53